๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This study is a 52-week, randomized, open, active-controlled trial of patie...
Status
Unknown
Location
RenJi Hospital
Start Date
2017-09-07
Trial ID
NCT02936375
Treatments Being Tested
This is an international trial conducted by three cooperative groups: SFOP ...
Status
Completed
Location
Morgan Stanley Childrens Hospital of New York Presbyterian
Start Date
1996-05
Trial ID
NCT00162656
Treatments Being Tested
This study aims to estimate the efficacy and side effects of study drugs in...
Status
Not Yet Recruiting
Location
Shenjing Hospital
Start Date
2019-06-01
Trial ID
NCT03892330
The primary objective is to cure multiple myeloma with less toxic allogenei...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2001-08
Trial ID
NCT00854139
20 patients with invasive castration resistant prostate cancer and radiolog...
Status
Completed
Location
Haukeland University Hospital Research Department
Start Date
2015-05
Trial ID
NCT02423928
Treatments Being Tested
Most pediatric patients with solid tumors respond to initial high-dose, int...
Status
Recruiting
Location
Miller Children's and Women's Hospital Long Beach
Start Date
2014-07
Trial ID
NCT02446431
Treatments Being Tested
Purpose of this Pilot Study: The investigators want to study the safety, si...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2012-10-09
Trial ID
NCT01701674
RATIONALE: A peripheral blood stem cell transplant or bone marrow transplan...
Status
Terminated
Location
Masonic Cancer Center at University of Minnesota
Start Date
2005-08
Trial ID
NCT00623077
RATIONALE: Monoclonal antibodies, such as rituximab, can locate cancer cell...
Status
Terminated
Location
Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Start Date
2004-10-05
Trial ID
NCT00060346
Treatments Being Tested
1. To evaluate the safety and tolerability of targeted AML1-ETO neoantigen ...
Status
Enrolling By Invitation
Location
Shenzhen University General Hospital
Start Date
2024-02-01
Trial ID
NCT06499025